The i2i Network is delighted to be building on our on-demand diabetes programmes designed for GP Clinical Pharmacists. With PCNs across England at varying stages of maturity, the Primary Care Diabetes Society’s (PCDS) guide to Best Practice in the Delivery of Diabetes Care in the Primary Care Network outlines the need for PCNs to form Diabetes Support Teams (DiaST) to enable joined-up diabetes care as part of a four-tier model. The PCN DiaST will be a new enhanced tier from within the existing PCN MDT underpinned by tier 1 practice-based diabetes care.
We will be hearing from expert pharmacists across primary and secondary care who are actively leading and implementing services at each tier.
Hannah is currently in an RPS Approved Consultant Pharmacist Post for Diabetes Awaiting Credentialing at NHS Leeds Clinical Commissioning Group (embedded in the Leeds GP Confederation). Hannah has vast experience in the lipid management area.
Hannah is co-chair of the United Kingdom Clinical Pharmacy Association’s Diabetes and Endocrine Committee and sits on the Diabetes UK Committee of Healthcare professionals. Hannah was a 2018 Diabetes UK Clinical Champion, a role which has allowed her to take an active part in designing and shaping regional and national agendas, aiding guideline development and delivering quality education both locally and nationally.
Clair Ranns is a Clinical Pharmacist, NHS Leeds CCG/Leeds GP Confederation, working in primary care and the Leeds Community Diabetes Service. She has a passion for diabetes and is a Diabetes UK Clinical Champion and member of the UKCPA Diabetes and Endocrinology group.
Anna Hodgkinson is a Consultant Pharmacist for Diabetes and works across primary care, intermediate care and secondary care. She has experience of working within the Lambeth community diabetes clinic, the Lambeth diabetes and renal clinic as well as the diabetes complications clinic at Guys and St Thomas’ NHS Foundation Trust.
By participating in this programme, you will:
This webinar has been funded by Novo Nordisk.
Speakers have not been paid to participate in this webinar.
Novo Nordisk has not had any input into the content or involvement in the creation of these materials. All materials have been developed independently by Soar Beyond and the i2i Network Faculty. (www.i2ipharmacists.co.uk/our-faculty). Soar Beyond owns all intellectual property rights for the resources and training and retains editorial rights at all times.
The intended audience is pharmacists working in general practice wanting to manage injectable therapies for patients with type 2 diabetes. This is to be used as a guide only and should be used to augment local guidelines or pathways. Pharmacists are encouraged to link with a GP prescribing/diabetes lead for supervision and
mentorship to support clinical competence.
Page Updated: August 2021
This workshop is no longer available.